This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Strength Seen in Salesforce.com (CRM): Can Its 4.0% Jump Turn into More Strength?
by Zacks Equity Research
Salesforce.com (CRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why Salesforce.com (CRM) Gained But Lagged the Market Today
by Zacks Equity Research
In the most recent trading session, Salesforce.com (CRM) closed at $326.84, indicating a +0.7% shift from the previous trading day.
Here's Why Investors Should Buy EPAM Systems Stock Right Now
by Zacks Equity Research
EPAM is rapidly expanding in the emerging AI space through partnerships and acquisitions, making it a promising player for 2025 and beyond.
Does a P/E Multiple of 6.67X Make Pitney Bowes a Strong Buy?
by Subham Roy
PBI stock presents an attractive investment opportunity, driven by its robust financial recovery, undervalued valuation and optimistic growth prospects.
The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences
by Zacks Equity Research
Salesforce, Shell and Gilead Sciences are included in this Analyst Blog.
Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc (SHEL) and Gilead Sciences, Inc. (GILD).
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Salesforce.com (CRM) closed at $323.54 in the latest trading session, marking a +1.4% move from the prior day.
UiPath Stock's 6-Month Consolidation: A Potential Buying Opportunity?
by Shuvra Shankar Dey
With PATH stock consolidating for six months, we assess its current status to decide on the best strategy for the future.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $326.90, marking a +0.61% move from the previous day.
Salesforce Up 27% in 2024: Will the Stock Sustain Momentum in 2025?
by Anirudha Bhagat
While CRM's long-term prospects shine brightly, slowing revenue growth and macroeconomic pressures warrant a cautious stance.
Reasons Why You Should Hold Docusign Stock in Your Portfolio
by Zacks Equity Research
DOCU is experiencing a rise in customer demand for its eSignature solution and is benefiting from adopting a subscription model.
Salesforce.com (CRM) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $330.66, representing a -1.1% change from its previous close.
Salesforce.com (CRM) Down 9.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UiPath Stock is Consolidating: Is This the Right Time to Enter?
by Shuvra Shankar Dey
Since PATH is consolidating for six months, we evaluate the stock's current position to determine how to play it now.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Will Pitney Bowes Stock Continue Its Uptrend After Gaining 66% YTD?
by Subham Roy
PBI stock offers a compelling investment opportunity, given its strong financial recovery, undervalued stock price and promising growth outlook.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Will Newly Launched Feature for Microsoft Teams Aid Five9 Stock?
by Zacks Equity Research
FIVN's new bi-directional presence feature for Microsoft Teams boosts collaboration, streamlines customer support and transforms contact center efficiency.
Is Invesco Large Cap Growth ETF (PWB) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PWB
Will Improved AI-Powered Illuminate Insights Benefit WDAY Stock?
by Supriyo Bose
Riding on a robust earnings surprise history and favorable Zacks Rank, WDAY appears primed for further stock price appreciation.
International Markets and Salesforce.com (CRM): A Deep Dive for Investors
by Zacks Equity Research
Explore how Salesforce.com's (CRM) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.